Skip to main content
. 2023 Mar 21;15(3):1005. doi: 10.3390/pharmaceutics15031005

Figure 2.

Figure 2

Figure 2

(A) Proton nuclear magnetic resonance data of FKFL-G2. (B) Matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry data of FKFL-G2. (C) Critical aggregation concentration of FKFL-G2.